Milestone Scientific reported third-quarter revenue of $2.2 million and a $748,000 net loss, but expects to approach or achieve profitability in the fourth quarter of 2026, supported by approximately $400,000 in additional annual savings.
MLSS · Milestone Scientific Inc.
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the issuance date of the accompanying unaudited condensed consolidated financial statements. As discussed in Note 2 to the accompanying unaudited condensed consolidated financial statements, management has concluded that its plans do not currently alleviate the substantial doubt regarding the Company’s ability to continue as a going concern within one year after the date the financial statements are issued.”View the 10-Q filed Nov 13, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Milestone Scientific Inc. reported substantial doubt about continuing as a going concern due to recurring losses and approximately $1.3 million in cash as of September 30, 2026, despite an April 20, 2026 private placement generating approximately $2.15 million.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MLSS
this stock
Milestone Scientific Inc.
|
$27.82M | +13.7% | +4.0% | — | 0.1% |
|
ISRG
Intuitive Surgical Inc
|
$153.77B | -21.7% | +20.5% | 53.8 | 2.0% |
|
BDX
Becton Dickinson & Co
|
$59.39B | — | +8.2% | 96.5 | 3.0% |
|
MDLN
Medline Inc.
|
$51.92B | -6.0% | +11.5% | — | 2.9% |
|
ALC
Alcon Inc
|
$35.61B | -6.0% | +10.5% | — | 3.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 13, 2026
- This year
- 20
Milestone Scientific Inc. reported substantial doubt about continuing as a going concern due to recurring losses and approximately $1.3 million in cash as of September 30, 2026, despite an April 20, 2026 private placement generating approximately $2.15 million.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MLSS | +1.7% | -6.0% | -17.0% | +0.8% | +13.7% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -0.9% | -4.8% | -17.5% | +1.0% | +3.1% |